|
Market Closed -
NSE India S.E.
14:05:07 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,366.00 INR | -0.53% |
|
-1.37% | -9.61% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 26.59x | 2.94x | 3.79x | 3.22x | 16.68x | 21.4x | 0.95% | 11.55B | ||
| 33.95x | 4.76x | 2.54x | 6.37x | 22.05x | 26.69x | 0.93% | 46.21B | ||
| 16.25x | 1.81x | 8.99x | 2.01x | 8.92x | 11.32x | 1.63% | 38.78B | ||
| 26.83x | 3.69x | -1.6x | 3.84x | 15.91x | 22.28x | 0.6% | 11.68B | ||
| 18.58x | 3.38x | 3.15x | 3.37x | 11.75x | 13.98x | 3.79% | 9.14B | ||
| 9.22x | 1.52x | 1.33x | 2.13x | 5.5x | 6.69x | 4.82% | 7.3B | ||
| 14.96x | 1.24x | 3.38x | 1.94x | 6.45x | 9.01x | 3.37% | 7.1B | ||
| 29.42x | 5.4x | 0.42x | 3.85x | 17.9x | 21.58x | 0.16% | 7.15B | ||
| 35.17x | 8.15x | 1.86x | 6.87x | 25.06x | 27.67x | 0.94% | 4.62B | ||
| 15.95x | 0.78x | -0.03x | 2.2x | 9.4x | 11.89x | 1.69% | 4.32B | ||
| 13.78x | 2.31x | 0.51x | 2.28x | 10.23x | 10.07x | 3.81% | 3.62B | ||
| 16.41x | 2.91x | -9.78x | 3.32x | 12.52x | 14.94x | 2.97% | 2.87B | ||
| 19.81x | 5.03x | 4.45x | 5.65x | 16.95x | 18.54x | 3.05% | 2.56B | ||
| 13.3x | - | -0.87x | 9.35x | 9.18x | 9.46x | - | 2.36B | ||
| 29.02x | - | -0.11x | - | - | - | - | 2.25B | ||
| 28.82x | 4.74x | 2.11x | - | - | - | - | 2.19B | ||
| Average | 21.75x | 3.48x | 1.26x | 4.03x | 13.46x | 16.11x | 2.21% | 10.23B | |
| Weighted average by Cap. | 23.90x | 3.38x | 3.37x | 4.00x | 14.81x | 18.23x | 1.66% |
- Stock Market
- Stocks
- CIPLA Stock
- Sector Cipla Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















